Zynerba Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2015 to Q2 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Zynerba Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2015 to Q2 2023.
  • Zynerba Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2023 was 53.9M shares, a 17.9% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 53.9M +8.19M +17.9% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 53.4M +10.9M +25.7% Mar 22, 2023 10-K 2023-03-28
Q3 2022 47.1M +5.85M +14.2% Nov 9, 2022 10-Q 2022-11-14
Q2 2022 45.8M +4.5M +10.9% Aug 8, 2022 10-Q 2022-08-10
Q1 2022 42.4M +1.2M +2.9% Feb 22, 2022 10-K 2022-03-01
Q3 2021 41.2M +11.8M +40% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 41.3M +12M +41% Aug 5, 2021 10-Q 2021-08-09
Q1 2021 41.3M +17.7M +75.1% Mar 5, 2021 10-K 2021-03-10
Q3 2020 29.4M +6.24M +26.9% Nov 5, 2020 10-Q 2020-11-09
Q2 2020 29.3M +6.06M +26.1% Aug 6, 2020 10-Q 2020-08-10
Q1 2020 23.6M +2.49M +11.8% Mar 4, 2020 10-K 2020-03-10
Q3 2019 23.2M +5.57M +31.6% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 23.2M +5.57M +31.6% Aug 2, 2019 10-Q 2019-08-06
Q1 2019 21.1M +7.51M +55.4% Mar 7, 2019 10-K 2019-03-11
Q3 2018 17.6M +4.07M +30.1% Nov 5, 2018 10-Q 2018-11-08
Q2 2018 17.6M +4.37M +32.9% Jul 31, 2018 10-Q 2018-08-02
Q1 2018 13.6M +347K +2.62% Mar 8, 2018 10-K 2018-03-12
Q3 2017 13.6M +3.6M +36.2% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 13.3M +4.06M +44.1% Jul 28, 2017 10-Q 2017-08-01
Q1 2017 13.2M +4.01M +43.6% Mar 24, 2017 10-K 2017-03-27
Q3 2016 9.95M +1.22M +14% Nov 11, 2016 10-Q 2016-11-14
Q2 2016 9.2M Aug 9, 2016 10-Q 2016-08-11
Q1 2016 9.2M Mar 10, 2016 10-K 2016-03-14
Q3 2015 8.73M Aug 27, 2015 10-Q 2015-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.